$PHCI
Panamera Holdings Corp

2023 Q4 Form 10-Q Financial Statement

#000164033423002334 Filed on December 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4
Revenue $25.00K
YoY Change 0.0%
Cost Of Revenue $22.90K
YoY Change 0.03%
Gross Profit $2.010K
YoY Change -4.6%
Gross Profit Margin 8.04%
Selling, General & Admin $64.91K
YoY Change 1080.18%
% of Gross Profit 3229.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $64.91K
YoY Change 1081.27%
Operating Profit -$62.90K
YoY Change 1756.58%
Interest Expense $919.00
YoY Change 10.32%
% of Operating Profit
Other Income/Expense, Net -$91.00
YoY Change -110.92%
Pretax Income -$62.99K
YoY Change 1392.35%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$62.99K
YoY Change 1392.35%
Net Earnings / Revenue -251.97%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 35.41M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $37.44K
YoY Change 1160.61%
Cash & Equivalents $37.44K
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables $8.333K
Other Receivables $0.00
Total Short-Term Assets $45.78K
YoY Change 256.16%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $45.78K
Total Long-Term Assets $0.00
Total Assets $45.78K
YoY Change 256.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.74K
YoY Change 62.68%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $28.40K
YoY Change -25.16%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $58.13K
YoY Change -8.96%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $58.13K
Total Long-Term Liabilities $0.00
Total Liabilities $58.13K
YoY Change -8.96%
SHAREHOLDERS EQUITY
Retained Earnings -$7.586M
YoY Change 1785.76%
Common Stock $4.141K
YoY Change 5.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$12.36K
YoY Change
Total Liabilities & Shareholders Equity $45.78K
YoY Change 256.16%

Cashflow Statement

Concept 2023 Q4
OPERATING ACTIVITIES
Net Income -$62.99K
YoY Change 1392.35%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$62.02K
YoY Change 1405.41%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$19.10K
YoY Change -577.55%
NET CHANGE
Cash From Operating Activities -$62.02K
Cash From Investing Activities
Cash From Financing Activities -$19.10K
Net Change In Cash -$81.13K
YoY Change 67504.17%
FREE CASH FLOW
Cash From Operating Activities -$62.02K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41410000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001620749
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41410000 shares
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6000000 shares
CY2023Q3 us-gaap Preferred Stock Discount On Shares
PreferredStockDiscountOnShares
50000000 usd
CY2023Q3 us-gaap Common Unit Issued
CommonUnitIssued
41410000 shares
CY2023Q3 us-gaap Common Unit Outstanding
CommonUnitOutstanding
35410000 shares
CY2022Q4 pnht Fixed Monthly Payment
FixedMonthlyPayment
8333 usd
CY2023Q4 dei Document Type
DocumentType
10-Q
CY2023Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q4 dei Document Period End Date
DocumentPeriodEndDate
2023-10-31
CY2023Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 dei Entity File Number
EntityFileNumber
000-55569
CY2023Q4 dei Entity Registrant Name
EntityRegistrantName
PANAMERA HOLDINGS CORPORATION
CY2023Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5707326
CY2023Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
5051 Westheimer, Suite 1200
CY2023Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2023Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77056
CY2023Q4 dei City Area Code
CityAreaCode
713
CY2023Q4 dei Local Phone Number
LocalPhoneNumber
878-7200
CY2023Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q4 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q4 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
41410000 shares
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37444 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118569 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8333 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8333 usd
CY2023Q4 pnht Employee Advanced Current
EmployeeAdvancedCurrent
0 usd
CY2023Q3 pnht Employee Advanced Current
EmployeeAdvancedCurrent
2700 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
45777 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
129602 usd
CY2023Q4 us-gaap Assets
Assets
45777 usd
CY2023Q3 us-gaap Assets
Assets
129602 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
29735 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
32385 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
28397 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
47499 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
58132 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
79884 usd
CY2023Q4 us-gaap Liabilities
Liabilities
58132 usd
CY2023Q3 us-gaap Liabilities
Liabilities
79884 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4141 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
4141 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7571794 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7570875 usd
CY2023Q4 pnht Common Stock Subscriptions Receivable On Related Parties Current
CommonStockSubscriptionsReceivableOnRelatedPartiesCurrent
-2000 usd
CY2023Q3 pnht Common Stock Subscriptions Receivable On Related Parties Current
CommonStockSubscriptionsReceivableOnRelatedPartiesCurrent
-2000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6000000 shares
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
600 usd
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
600 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7585690 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7522698 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-12355 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
49718 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45777 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129602 usd
CY2023Q4 pnht Revenues Related Party
RevenuesRelatedParty
25000 usd
CY2022Q4 pnht Revenues Related Party
RevenuesRelatedParty
25001 usd
CY2023Q4 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
22990 usd
CY2022Q4 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
22894 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
2010 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
2107 usd
CY2023Q4 us-gaap Professional Fees
ProfessionalFees
22894 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
5052 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42017 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
443 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
64911 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
5495 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-62901 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3388 usd
CY2023Q4 us-gaap Interest Income Other
InterestIncomeOther
828 usd
CY2022Q4 us-gaap Interest Income Other
InterestIncomeOther
0 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
919 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
833 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-91 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-833 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-62992 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-4221 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-62992 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-4221 usd
CY2023Q4 pnht Earnings Per Share Basic And Diluted Common Stock
EarningsPerShareBasicAndDilutedCommonStock
-0.00
CY2022Q4 pnht Earnings Per Share Basic And Diluted Common Stock
EarningsPerShareBasicAndDilutedCommonStock
-0.00
CY2023Q4 pnht Weighted Average Number Of Basic And Diluted Shares Outstanding
WeightedAverageNumberOfBasicAndDilutedSharesOutstanding
35410000 shares
CY2022Q4 pnht Weighted Average Number Of Basic And Diluted Shares Outstanding
WeightedAverageNumberOfBasicAndDilutedSharesOutstanding
39210000 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
49718 usd
CY2023Q4 pnht Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
919 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-62992 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-12355 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-47614 usd
CY2022Q4 pnht Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
833 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-51002 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-62992 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-4221 usd
CY2023Q4 pnht Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
919 usd
CY2022Q4 pnht Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
833 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2650 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1244 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1 usd
CY2023Q4 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
CY2022Q4 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-400 usd
CY2023Q4 us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
0 usd
CY2022Q4 us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
-1500 usd
CY2023Q4 pnht Increase Decrease In Payroll Liabilities Related Party
IncreaseDecreaseInPayrollLiabilitiesRelatedParty
0 usd
CY2022Q4 pnht Increase Decrease In Payroll Liabilities Related Party
IncreaseDecreaseInPayrollLiabilitiesRelatedParty
-75 usd
CY2023Q4 pnht Increase Decrease In Employee Advanced New
IncreaseDecreaseInEmployeeAdvancedNew
2700 usd
CY2022Q4 pnht Increase Decrease In Employee Advanced New
IncreaseDecreaseInEmployeeAdvancedNew
0 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-62023 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4120 usd
CY2023Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2022Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4000 usd
CY2023Q4 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
19102 usd
CY2022Q4 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19102 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-81125 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-120 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
118569 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3087 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37444 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2967 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.</p>
CY2023Q4 pnht Fixed Monthly Payment
FixedMonthlyPayment
8333 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7585690 usd
CY2023Q4 us-gaap Revenues
Revenues
25000 usd
CY2023Q4 pnht Shareholder Financed For Operation Expense
ShareholderFinancedForOperationExpense
0 usd
CY2022Q4 pnht Shareholder Financed For Operation Expense
ShareholderFinancedForOperationExpense
4000 usd
CY2023Q4 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
19102 usd
CY2022Q4 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
CY2023Q4 pnht Loan To Related Parties
LoanToRelatedParties
28397 usd
CY2023Q3 pnht Loan To Related Parties
LoanToRelatedParties
47499 usd
CY2023Q4 pnht Interest On Related Party Loans
InterestOnRelatedPartyLoans
919 usd
CY2022Q4 pnht Interest On Related Party Loans
InterestOnRelatedPartyLoans
833 usd
CY2023Q4 us-gaap Salaries And Wages
SalariesAndWages
21725 usd
CY2022Q4 us-gaap Salaries And Wages
SalariesAndWages
0 usd
CY2023Q4 us-gaap Preferred Stock Discount On Shares
PreferredStockDiscountOnShares
50000000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Unit Issued
CommonUnitIssued
35410000 shares
CY2023Q4 us-gaap Common Unit Outstanding
CommonUnitOutstanding
35410000 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6000000 shares
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
600 usd
CY2023Q4 pnht Fixed Monthly Payment
FixedMonthlyPayment
8333 usd
CY2023Q4 us-gaap Revenues
Revenues
25000 usd
CY2022Q4 us-gaap Revenues
Revenues
25001 usd
CY2023Q4 pnht Accounts Receivable Diverted Current
AccountsReceivableDivertedCurrent
8333 usd
CY2022Q4 pnht Accounts Receivable Diverted Current
AccountsReceivableDivertedCurrent
8333 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
22900 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
22894 usd

Files In Submission

Name View Source Status
0001640334-23-002334-index-headers.html Edgar Link pending
0001640334-23-002334-index.html Edgar Link pending
0001640334-23-002334.txt Edgar Link pending
0001640334-23-002334-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pnht-20231031.xsd Edgar Link pending
pnht_10q.htm Edgar Link pending
pnht_ex311.htm Edgar Link pending
pnht_ex312.htm Edgar Link pending
pnht_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
pnht-20231031_pre.xml Edgar Link unprocessable
pnht-20231031_lab.xml Edgar Link unprocessable
pnht-20231031_cal.xml Edgar Link unprocessable
pnht-20231031_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pnht_10q_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending